Anesthetic agents can be a target of formulary management efforts and result in significant cost savings, says Laura Pizzi, PharmD. As a fellow at the University of Pennsylvania Medical Center (UPMC), Philadelphia, she evaluated a skeletal muscle blocker (SMB) intervention that achieved estimated ...

No Results Found.